Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD 39.65
-0.15 (-0.38%)
May 2, 2025, 2:00 PM CST
TPEX:7427 Revenue
In the year 2024, Great Novel Therapeutics Biotech & Medicals had annual revenue of 1.69M TWD, down -65.26%. Great Novel Therapeutics Biotech & Medicals had revenue of 1.16M in the half year ending December 31, 2024.
Revenue
1.69M
Revenue Growth
-65.26%
P/S Ratio
1,034.76
Revenue / Employee
93.61K
Employees
18
Market Cap
1.74B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Polaris Group | 107.00M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |